Literature DB >> 8938803

Erbium: YAG laser ablation on human trabecular meshwork by contract delivery endoprobes.

T S Dietlein1, P C Jacobi, G K Krieglstein.   

Abstract

BACKGROUND AND
OBJECTIVE: Photoablation of the trabecular meshwork by the infrared laser is an experimental mode of glaucoma surgery.
MATERIALS AND METHODS: The authors studied different quartz fiber tips in erbium:YAG laser trabecular ablation. End-firing endoprobes (200 and 320 microns in core diameter) and a side-firing slope tip (200 microns in core diameter) were used. Ablation zones and collateral tissue damage in the trabecular meshwork of human donor eyes were analyzed using light and scanning electron microscopy.
RESULTS: The 320-micron end-firing endoprobe most effectively photoablated trabecular tissue by creating large circular craters. The side-firing endoprobe yielded smaller elliptic apertures in the trabecular meshwork. Collateral tissue damage was similar for all endoprobes using pulse energies of 4 and 6 mJ. Transmission impairment was obvious for all quartz fiber tips following frequent use.
CONCLUSION: Larger end-firing contact fiberoptic probes provide larger ablation areas in the trabecular meshwork without augmentation of collateral tissue damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938803

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  3 in total

1.  Ab interno infrared laser trabecular ablation: preliminary short-term results in patients with open-angle glaucoma.

Authors:  T S Dietlein; P C Jacobi; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 2.  Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery.

Authors:  Kevin Kaplowitz; Joel S Schuman; Nils A Loewen
Journal:  Br J Ophthalmol       Date:  2013-12-12       Impact factor: 4.638

3.  Combined cataract and glaucoma surgery: endoscope-controlled erbium:YAG-laser goniotomy versus trabeculectomy.

Authors:  Heiko Philippin; Sonja Wilmsmeyer; Nicolas Feltgen; Thomas Ness; Jens Funk
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-02-02       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.